The weekly litigation news digest is live. Subscribe now

Neurodyn Life Sciences competitive analysis

Loading summary...

Explore Neurodyn Life Sciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Oct 3, 2018Progranulin For Use In Treating Parkinson'S Disease Or Alzheimer'S Disease2

Latest PTAB cases involving Neurodyn Life Sciences

Discover the latest PTAB cases involving Neurodyn Life Sciences, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Neurodyn Life Sciences with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NEURODYN LIFE SCIENCES - 2 - -
CMS CAMERON MCKENNA NABARRO OLSWANG11 - - -
MATHYS & SQUIRE54 - - -